Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers

Ruscetti, M., Leibold, J., Bott, M. J., Shields, M., Chen, C. C., Fennell, M., Chen, H. C., Baslan, T., Salgado, N. R., Manchado, E., Low, V., Poirier, J. T., Rudin, C. M., de Stanchina, E., Egeblad, M., Sherr, C. J., Lowe, S. W. (May 2018) Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers. Cancer Research, 78 (10 Sup). ISSN 0008-5472

Item Type:	Paper
Additional Information:	Meeting Abstract
Subjects:	bioinformatics > genomics and proteomics > genetics & nucleic acid processing > DNA, RNA structure, function, modification > genes, structure and function > genes: types > KRAS diseases & disorders > cancer > cancer types > lung cancer Publication Type > Meeting Abstract
CSHL Authors:	Shields, Mario Egeblad, Mikala
Communities:	CSHL labs > Egeblad lab
Depositing User:	Matt Covey
Date:	May 2018
Date Deposited:	01 Jun 2018 16:29
Last Modified:	01 Jun 2018 16:29
URI:	https://repository.cshl.edu/id/eprint/36712

Actions (login required)

Administrator's edit/view item